{{Rsnum
|rsid=2549513
|Chromosome=16
|position=79516830
|Orientation=plus
|GMAF=0.1529
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 82.3 | 17.7 | 0.0
| HCB | 81.0 | 16.8 | 2.2
| JPT | 86.7 | 12.4 | 0.9
| YRI | 51.4 | 37.7 | 11.0
| ASW | 66.7 | 29.8 | 3.5
| CHB | 81.0 | 16.8 | 2.2
| CHD | 83.5 | 15.6 | 0.9
| GIH | 78.2 | 21.8 | 0.0
| LWK | 38.2 | 45.5 | 16.4
| MEX | 84.5 | 15.5 | 0.0
| MKK | 45.5 | 46.8 | 7.7
| TSI | 71.6 | 28.4 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22856164
|Title=[Evaluation of association between 9 genetic polymorphism and myocardial infarction in the Siberian population]
}}

{{PMID Auto
|PMID=17903304
|Title=Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.
|OA=1
}}

{{PMID Auto
|PMID=20017983
|Title=Evaluation of population impact of candidate polymorphisms for coronary heart disease in the Framingham Heart Study Offspring Cohort.
|OA=1
}}

{{PMID Auto
|PMID=22042884
|Title=Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study.
|OA=1
}}

{{PMID Auto
|PMID=24087953
|Title=[Genetic predictors of myocardial infarction in subjects of young age]
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}